Wanbangde Pharmaceutical Holding Group Co., Ltd.

XSEC:002082 Stock Report

Market Cap: CN¥4.2b

Wanbangde Pharmaceutical Holding Group Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Shouming Zhao

Chief executive officer

CN¥980.0k

Total compensation

CEO salary percentagen/a
CEO tenure7.4yrs
CEO ownership8.1%
Management average tenureno data
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO

Shouming Zhao (60 yo)

7.4yrs

Tenure

CN¥980,000

Compensation

Mr. Shouming Zhao is GM & Chairman of the Board of Wanbangde Pharmaceutical Holding Group Co. Ltd. Mr. Zhao was Chairman, GM & CFO of Wanbangde Pharmaceutical Holding Group Co. Ltd. Mr. Zhao was Chairman &...

Board Members

NamePositionTenureCompensationOwnership
Shouming Zhao
GM & Chairman of the Board7.4yrsCN¥980.00k8.12%
CN¥ 338.3m
Wang Tianfang
Financial Director & Non-Independent Director1.4yrsCN¥187.50k0.00065%
CN¥ 27.1k
Tongke Liu
Deputy GM7.4yrsCN¥600.00kno data
Gengsheng Huang
Supervisor1.4yrsno datano data
Hugen Wang
Chairman of the Supervisory Board7.4yrsno datano data
Hui Zhuang
Vice Chairman of the Board7.4yrsno data4.62%
CN¥ 192.3m
Bin Han
Non-Independent Director7.4yrsno datano data
Yuejiang Zhou
Independent Director4.8yrsCN¥100.00kno data
Lin Hong
Non-Independent Director1.4yrsCN¥187.50kno data
Li Yang
Independent Director1.4yrsCN¥41.70kno data
Yanzhou Zhang
Independent Director1.4yrsCN¥41.70kno data

4.8yrs

Average Tenure

59yo

Average Age

Experienced Board: 002082's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 12:05
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Wanbangde Pharmaceutical Holding Group Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhipeng ZhangAJ Securities Co., Ltd
Guoxian JuFirst Capital Securities Co. LTD.
Xinrong DengFounder Securities Co., Ltd.